Cardiorespiratory effects of a cardioselective muscarinic antagonist in anesthetized horses.

This research investigates the effects of a specific drug, methoctramine, on the heart and lung functions of anesthetized horses. The study is primarily concerned with understanding the treatment prospect of slow heart rate or bradycardia in horses.

Study Background

• The use of drugs known as nonselective antimuscarinics for managing bradycardia, a condition characterized by a slower than normal heart rate, in horses has often been overlooked in veterinary medicine. The hesitancy is primarily due to these drugs’ potential to negatively affect the movement or motility of the digestive tract.
• In this context, the researchers chose to examine the effects of a specific muscarinic antagonist, methoctramine (MET), which preferentially targets the M2 subtype of muscarinic receptors predominantly found in the heart. This ‘cardioselectivity’ implies that the drug might be effective in managing bradycardia without adversely affecting the horse’s digestive function.

The Role of Methoctramine

• Methoctramine is a muscarinic antagonist; such substances dampen the effects of acetylcholine, a neurotransmitter that, among other functions, can slow heart rate.
• Thus, the use of methoctramine could hypothetically counteract the slow heart rate seen with bradycardia.

Previous In Vitro Study

• Prior to this study, the researchers conducted in vitro (in the lab) research to study the effects of methoctramine. They found that they needed to use very high doses of the drug to inhibit the contractions of the longitudinal smooth muscle in the horse’s small intestine (jejunal) induced by acetylcholine.
• This finding led the researchers to hypothesize that methoctramine, in high doses, may be useful for treating bradycardia in horses while sparing the motility of the intestine.

The Present Study

• This research study takes the in vitro findings a step further by administering MET to anesthetized horses. The use of anesthesia allows for the safe and controlled study of the drug’s effects on the horse’s heart and lung functions.